# Lansoprazole

NDC: 72603-313
Generic name: Lansoprazole
Labeler / Manufacturer: NorthStar Rx LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Routes: ORAL
Marketing started: 20230328

FDA application: ANDA207167

## Active ingredients

- LANSOPRAZOLE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72603-313"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72603-313
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac051296-6fe3-4ab5-a001-cc3e06199a22